[Basic treatment of migraine].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D004087:Dihydroergotamine / Q000627:therapeutic use*; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D012702:Serotonin Antagonists / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D012702:Serotonin Antagonists; D004087:Dihydroergotamine
Traitement de fond de la migraine.